Cover Image
市場調查報告書

HIV-2感染疾病:全球臨床實驗檢討

HIV-2 Infection Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 321705
出版日期 內容資訊 英文 99 Pages
訂單完成後即時交付
價格
Back to Top
HIV-2感染疾病:全球臨床實驗檢討 HIV-2 Infection Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月22日 內容資訊: 英文 99 Pages
簡介

本報告提供HIV-2感染疾病的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • HIV-2感染疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5個國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:感染疾病臨床實驗上HIV-2感染疾病所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病臨床實驗上HIV-2感染疾病所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

HIV-2感染疾病治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Bristol-Myers Squibb Company
    • Gilead Sciences, Inc.
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • C. H. Boehringer Sohn AG & Co. KG
    • Abbott Laboratories
    • AbbVie Inc.
    • BioCryst Pharmaceuticals, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • French National Agency for Research on AIDS and Viral Hepatitis
    • University of California, San Francisco
    • Centers for Disease Control and Prevention
    • National Center for Complementary and Alternative Medicine
    • Emory University
    • University of Washington
    • Hospital Clinic de Barcelona
    • University of Miami
    • Stanford University

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2483CTIDB

GlobalData's clinical trial report, "HIV-2 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-2 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-2 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-2 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • HIV-2 Infection
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of HIV-2 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of HIV-2 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of HIV-2 Infection
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in HIV-2 Infection Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • BioCryst Pharmaceuticals, Inc.
      • Clinical Trial Overview of BioCryst Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • French National Agency for Research on AIDS and Viral Hepatitis
      • Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • National Center for Complementary and Alternative Medicine
      • Clinical Trial Overview of National Center for Complementary and Alternative Medicine
      • Emory University
      • Clinical Trial Overview of Emory University
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Hospital Clinic de Barcelona
      • Clinical Trial Overview of Hospital Clinic de Barcelona
      • University of Miami
      • Clinical Trial Overview of University of Miami
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • HIV-2 Infection Therapeutics, Global, Clinical Trials by Region, 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials by Phase, 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • HIV-2 Infection Therapeutics, Global, Suspended Clinical Trials, 2014*
  • HIV-2 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • HIV-2 Infection Therapeutics, Global, Terminated Clinical Trials, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • HIV-2 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*

List of Figures

  • HIV-2 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • HIV-2 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of HIV-2 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • HIV-2 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • HIV-2 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • HIV-2 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • HIV-2 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top